FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225137024> ?p ?o ?g. }

• W4225137024 endingPage "502" @default.
• W4225137024 startingPage "492" @default.
• W4225137024 abstract "Summary CD19 CAR‐T have emerged as a new standard treatment for relapsed/refractory (r/r) large B‐cell lymphoma (LBCL). CAR‐T real‐world (RW) outcomes published to date suggest significant variability across countries. We provide results of a large national cohort of patients intended to be treated with CAR‐T in the UK. Consecutive patients with r/r LBCL approved for CAR‐T by the National CAR‐T Clinical Panel between December 2018 and November 2020 across all UK CAR‐T centres were included. 404/432 patients were approved [292 axicabtagene ciloleucel (axi‐cel), 112 tisagenlecleucel (tisa‐cel)], 300 (74%) received the cells. 110/300 (38.3%) patients achieved complete remission (CR) at 6 months (m). The overall response rate was 77% (52% CR) for axi‐cel, 57% (44% CR) for tisa‐cel. The 12‐month progression‐free survival was 41.8% (axi‐cel) and 27.4% (tisa‐cel). Median overall survival for the intention‐to‐treat population was 10.5 m, 16.2 m for infused patients. The incidence of grade ≥3 cytokine release syndrome and neurotoxicity were 7.6%/19.6% for axi‐cel and 7.9%/3.9% for tisa‐cel. This prospective RW population of CAR‐T eligible patients offers important insights into the clinical benefit of CD19 CAR‐T in LBCL in daily practice. Our results confirm long‐term efficacy in patients receiving treatment similar to the pivotal trials, but highlight the significance of early CAR‐T failure." @default.
• W4225137024 created "2022-05-01" @default.
• W4225137024 creator A5000935668 @default.
• W4225137024 creator A5016790466 @default.
• W4225137024 creator A5018708168 @default.
• W4225137024 creator A5019014469 @default.
• W4225137024 creator A5019801005 @default.
• W4225137024 creator A5020447255 @default.
• W4225137024 creator A5020848929 @default.
• W4225137024 creator A5021186773 @default.
• W4225137024 creator A5021965002 @default.
• W4225137024 creator A5022624109 @default.
• W4225137024 creator A5025217094 @default.
• W4225137024 creator A5025768159 @default.
• W4225137024 creator A5026456735 @default.
• W4225137024 creator A5027793525 @default.
• W4225137024 creator A5037678182 @default.
• W4225137024 creator A5042943966 @default.
• W4225137024 creator A5045820092 @default.
• W4225137024 creator A5051145779 @default.
• W4225137024 creator A5051711186 @default.
• W4225137024 creator A5053161231 @default.
• W4225137024 creator A5055724074 @default.
• W4225137024 creator A5057669440 @default.
• W4225137024 creator A5059408279 @default.
• W4225137024 creator A5062131009 @default.
• W4225137024 creator A5067993718 @default.
• W4225137024 creator A5071138712 @default.
• W4225137024 creator A5071608606 @default.
• W4225137024 creator A5072606251 @default.
• W4225137024 creator A5073895943 @default.
• W4225137024 creator A5074570151 @default.
• W4225137024 creator A5077013079 @default.
• W4225137024 creator A5079539291 @default.
• W4225137024 creator A5080864734 @default.
• W4225137024 creator A5081252933 @default.
• W4225137024 creator A5084271514 @default.
• W4225137024 creator A5085863943 @default.
• W4225137024 creator A5090236260 @default.
• W4225137024 date "2022-04-29" @default.
• W4225137024 modified "2023-10-17" @default.
• W4225137024 title "A national service for delivering <scp>CD19 CAR‐T</scp> in large B‐cell lymphoma – The <scp>UK</scp> real‐world experience" @default.
• W4225137024 cites W2119147717 @default.
• W4225137024 cites W2744261860 @default.
• W4225137024 cites W2773804840 @default.
• W4225137024 cites W2903062212 @default.
• W4225137024 cites W2903225254 @default.
• W4225137024 cites W2905654445 @default.
• W4225137024 cites W2990485716 @default.
• W4225137024 cites W2991110530 @default.
• W4225137024 cites W2991246146 @default.
• W4225137024 cites W3024978145 @default.
• W4225137024 cites W3043369050 @default.
• W4225137024 cites W3082855561 @default.
• W4225137024 cites W3090872582 @default.
• W4225137024 cites W3105850195 @default.
• W4225137024 cites W3157290121 @default.
• W4225137024 cites W3176832074 @default.
• W4225137024 cites W3176860182 @default.
• W4225137024 cites W4221125141 @default.
• W4225137024 doi "https://doi.org/10.1111/bjh.18209" @default.
• W4225137024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35485402" @default.
• W4225137024 hasPublicationYear "2022" @default.
• W4225137024 type Work @default.
• W4225137024 citedByCount "25" @default.
• W4225137024 countsByYear W42251370242022 @default.
• W4225137024 countsByYear W42251370242023 @default.
• W4225137024 crossrefType "journal-article" @default.
• W4225137024 hasAuthorship W4225137024A5000935668 @default.
• W4225137024 hasAuthorship W4225137024A5016790466 @default.
• W4225137024 hasAuthorship W4225137024A5018708168 @default.
• W4225137024 hasAuthorship W4225137024A5019014469 @default.
• W4225137024 hasAuthorship W4225137024A5019801005 @default.
• W4225137024 hasAuthorship W4225137024A5020447255 @default.
• W4225137024 hasAuthorship W4225137024A5020848929 @default.
• W4225137024 hasAuthorship W4225137024A5021186773 @default.
• W4225137024 hasAuthorship W4225137024A5021965002 @default.
• W4225137024 hasAuthorship W4225137024A5022624109 @default.
• W4225137024 hasAuthorship W4225137024A5025217094 @default.
• W4225137024 hasAuthorship W4225137024A5025768159 @default.
• W4225137024 hasAuthorship W4225137024A5026456735 @default.
• W4225137024 hasAuthorship W4225137024A5027793525 @default.
• W4225137024 hasAuthorship W4225137024A5037678182 @default.
• W4225137024 hasAuthorship W4225137024A5042943966 @default.
• W4225137024 hasAuthorship W4225137024A5045820092 @default.
• W4225137024 hasAuthorship W4225137024A5051145779 @default.
• W4225137024 hasAuthorship W4225137024A5051711186 @default.
• W4225137024 hasAuthorship W4225137024A5053161231 @default.
• W4225137024 hasAuthorship W4225137024A5055724074 @default.
• W4225137024 hasAuthorship W4225137024A5057669440 @default.
• W4225137024 hasAuthorship W4225137024A5059408279 @default.
• W4225137024 hasAuthorship W4225137024A5062131009 @default.
• W4225137024 hasAuthorship W4225137024A5067993718 @default.
• W4225137024 hasAuthorship W4225137024A5071138712 @default.
• W4225137024 hasAuthorship W4225137024A5071608606 @default.
• W4225137024 hasAuthorship W4225137024A5072606251 @default.
• W4225137024 hasAuthorship W4225137024A5073895943 @default.
• W4225137024 hasAuthorship W4225137024A5074570151 @default.

• next